Early Signs of Efficacy Study With Riociguat in Adult Homozygous Delta F508 Cystic Fibrosis Patients

Stopped Study was terminated after completion of Part 1, because Part 2 was no longer appropriate.

Conditions

• Cystic Fibrosis

Interventions

• DRUG: Riociguat (Adempas, BAY63-2521)
• DRUG: Placebo

Sponsor

Bayer

Collaborators

• [object Object]